Bear in mind that ArtemiC is an anti-inflamatory - so used in treatment rather than a cure or a vaccine. Also that 100's of companies are involved and MXC is just one of those.
However, if the formulation can assist then maybe this could be a good break for MXC. God knows, MXC could do with one.
Ann: COVID-19 Clinical Trial Site Expansion into India, page-13
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.025(7.94%) |
Mkt cap ! $13.13M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 29.0¢ | $688 | 2.372K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1033 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 11.01am 03/07/2024 (20 minute delay) ? |
| RGT (ASX) Chart |